| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial.
Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial.
Garland EL, Recasens M, Taple BJ, Donaldson GW, Weisberg RB.
Ann Med. 2024 Dec;56(1):2392870. doi: 10.1080/07853890.2024.2392870. Epub 2024 Aug 22. PMID: 39172534; PMCID: PMC11342816.